Credits
Data sources and attribution
Last updated: 2 November 2026
GenSight (Genassis Insights) is built on public and licensed data from the organisations below. Genassis processes, normalises and links this data. It is not an official record of any of these organisations, and none of them endorses GenSight.
Mondo Disease Ontology
Attribution required · CC BY 4.0
Disease identifiers (MONDO ids) and names used to link conditions across sources.
Data from Mondo Disease Ontology (https://mondo.monarchinitiative.org), release 2026-09-01, licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Genassis has processed and linked this data; changes were made. Not endorsed by the Monarch Initiative.
Medical Subject Headings (MeSH)
Attribution required · NLM terms and conditions for downloaded data
Medical vocabulary used to name and group conditions and topics.
Courtesy of the U.S. National Library of Medicine.
https://www.nlm.nih.gov/databases/download/terms_and_conditions.html
ClinicalTrials.gov
Attribution required · ClinicalTrials.gov Terms and Conditions
Clinical trial registrations and results.
Source: ClinicalTrials.gov (U.S. National Library of Medicine). Genassis has processed, normalised and linked this data; it is not an official ClinicalTrials.gov record.
PubMed
Attribution required · NLM terms and conditions for downloaded data
Titles, abstracts and bibliographic records of published literature.
Courtesy of the U.S. National Library of Medicine. Abstracts may be protected by copyright held by journal publishers or authors.
https://www.nlm.nih.gov/databases/download/terms_and_conditions.html
DailyMed
Attribution required · NLM terms and conditions for downloaded data
US product labels.
Courtesy of the U.S. National Library of Medicine.
https://www.nlm.nih.gov/databases/download/terms_and_conditions.html
openFDA
Credit requested · CC0 1.0 Universal
US product labels, adverse event reports (FAERS) and NDC product data.
Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
U.S. Food and Drug Administration
Credit requested · Public domain
Approvals, review documents, shortages, Orange Book and Purple Book listings.
Source: U.S. Food and Drug Administration (https://www.fda.gov).
https://www.fda.gov/about-fda/about-website/website-policies
U.S. Securities and Exchange Commission (EDGAR)
Credit requested · Free to access and reuse
Company filings (10-K, 8-K).
Source: U.S. Securities and Exchange Commission (EDGAR).
Open Targets Platform
Credit requested · CC0 1.0
Drug, target and mechanism reference data.
Open Targets Platform. Buniello, A. et al. (2025), Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research.
ChEMBL
Attribution required · Creative Commons Attribution-ShareAlike 3.0 Unported
Drug and mechanism records distributed within the Open Targets Platform.
ChEMBL, EMBL-EBI. Zdrazil, B. et al. (2023), Nucleic Acids Research; Davies, M. et al. (2015), Nucleic Acids Research 43(W1):W612-20. Provided under CC BY-SA 3.0.
https://chembl.gitbook.io/chembl-interface-documentation/about
European Medicines Agency (EMA)
Attribution required · EMA legal notice: reuse permitted when EMA is acknowledged
Assessment reports, product information, registers and committee documents.
Source: European Medicines Agency (https://www.ema.europa.eu). © EMA.
NHS Business Services Authority (NHSBSA)
Attribution required · Open Government Licence
Drug Tariff and Serious Shortage Protocols.
NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
MHRA and GOV.UK
Attribution required · Open Government Licence v3.0
Drug Safety Update and device alerts.
Contains public sector information licensed under the Open Government Licence v3.0.
Haute Autorité de santé (HAS)
Attribution required · Free re-use with source and date cited, content unaltered
French opinions, recommendations and decisions.
Document de la Haute Autorité de santé, disponible sur le site www.has-sante.fr
AOTMiT (Poland)
Attribution required · Use permitted with the source indicated
Polish HTA agency publications.
Source: Agencja Oceny Technologii Medycznych i Taryfikacji (AOTMiT), https://www.aotm.gov.pl
National Institute for Health and Care Excellence (NICE)
Source acknowledged
Guidance and committee documents.
Source: National Institute for Health and Care Excellence (NICE).
Gemeinsamer Bundesausschuss (G-BA)
Source acknowledged
Benefit assessment decisions and supporting documents.
Source: Gemeinsamer Bundesausschuss (G-BA).
Centers for Medicare & Medicaid Services (CMS)
Source acknowledged
Drug pricing and utilisation data.
Source: Centers for Medicare & Medicaid Services (CMS).
State Medicaid drug utilisation review boards
Source acknowledged
Published board and preferred drug list documents (Illinois, Oregon, Washington).
Source: the respective state Medicaid programmes.
Clinical guideline publishers (NCCN, ESMO, Annals of Oncology)
Source acknowledged
Guideline recommendations.
Source: NCCN, ESMO and Annals of Oncology. Guideline content remains the property of its publishers.
News and agency feeds
Source acknowledged
Headlines and links from trade publications and regulator feeds, each attributed to its publisher at the item.
Each item names and links to its original publisher.
Questions about a source or a credit: support@genassis.ai